{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:45:14Z","timestamp":1791330314321,"version":"4.3.1"},"reference-count":21,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:00:00Z","timestamp":1228867200000},"content-version":"vor","delay-in-days":4941,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Liver"],"published-print":{"date-parts":[[1995,6]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> A high prevalence of HCV infection has been reported in patients with hepatocellular carcinoma. The progression from acute transfusion\u2010associated hepatitis to hepatic cirrhosis and hepatocellular carcinoma has been suggested in several studies to be very long. We have investigated the prevalence of anti\u2010HCV and the interval between HCV infection and hepatocellular carcinoma among 191 consecutive patients with cirrhosis and liver\u2010cell carcinoma. Serum samples from 191 patients with cirrhosis and hepatocellular carcinoma, consecutively diagnosed in our hospital between 1988 and 1993, were tested for serological markers of HBV and HCV infection. One hundred and forty\u2010eight patients (77.5%; 95% confidence interval (c.i): 76% to 80%) were anti\u2010HCV positive by 2nd generation enzyme immunoassay (confirmed by 2nd generation recombinant immunoblot assay) and 152 patients (79.5%; 95% c.i: 76% to 80%) were anti\u2010HCV positive by 3rd generation enzyme immunoassay, while only 14 (7.4%; 95% c.i: 5% to 10%) were HBsAg positive. Of the 29 anti\u2010HCV positive patients with previous transfusion, the interval between the date of blood transfusion and the diagnosis of hepatic cirrhosis was 24\u00b112.5 years and that of hepatocellular carcinoma was 26.8\u00b112.4 years. These results confirm the high prevalence of HCV infection in patients with hepatocellular carcinoma and the slow sequential progression from HCV infection through cirrhosis and hepatocellular carcinoma.<\/jats:p>","DOI":"10.1111\/j.1600-0676.1995.tb00664.x","type":"journal-article","created":{"date-parts":[[2010,8,10]],"date-time":"2010-08-10T20:00:33Z","timestamp":1281470433000},"page":"159-163","source":"Crossref","is-referenced-by-count":48,"title":["Long interval between HCV infection and development of hepatocellular carcinoma"],"prefix":"10.1111","volume":"15","author":[{"given":"Luis","family":"Castells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Guardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,10]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90585-7"},{"key":"e_1_2_1_3_2","first-page":"21s","article-title":"Hepatitis B virus as the etiologic agent in hepatocellular carcinoma. Epidemiologic considerations","volume":"2","author":"Beasley R P.","year":"1982","journal-title":"Hepatology"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198206103062302"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120321"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01317042"},{"key":"e_1_2_1_7_2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0016-5085(83)90336-0","article-title":"Non\u2010A, non\u2010B hepatitis. I. Recognition, epidemiology, and clinical features","volume":"85","author":"Dienstag J L.","year":"1983","journal-title":"Gastroenterology"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-6-794"},{"key":"e_1_2_1_9_2","first-page":"7294","article-title":"Increasing incidence of hepatocellular carcinoma possibly associated with non\u2010A, non\u2010B hepatitis in Japan, disclosed by hepatitis B virus DNA analysis of surgical resected cases","volume":"48","author":"Sakamoto M.","year":"1988","journal-title":"Cancer Res"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2496467"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91015-5"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)91016-7"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-2-97"},{"key":"e_1_2_1_14_2","first-page":"441","article-title":"Carcinoma hepatocellular: clinica, diagn\u00f3stico y supervivencia en 140 casos","volume":"100","author":"Castells LI","year":"1993","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(92)90156-J"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120409"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120323"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920115)69:2<342::AID-CNCR2820690211>3.0.CO;2-T"},{"key":"e_1_2_1_19_2","first-page":"253","volume-title":"Progress in liver diseases","author":"Esteban J I","year":"1992"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199212313272703"},{"key":"e_1_2_1_21_2","first-page":"35","volume-title":"Etiology, pathology and treatment of hepatocellular carcinoma in North America","author":"Bosch F X","year":"1991"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91523-7"}],"container-title":["Liver"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0676.1995.tb00664.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0676.1995.tb00664.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T16:03:31Z","timestamp":1698249811000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0676.1995.tb00664.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["10.1111\/j.1600-0676.1995.tb00664.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0676.1995.tb00664.x","archive":["Portico"],"relation":{},"ISSN":["0106-9543","1600-0676"],"issn-type":[{"value":"0106-9543","type":"print"},{"value":"1600-0676","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}